AI4Eyes Completes FDA Registration and Listing for its Eye Care Platform, Opening the Path to U.S. Commercialization

MONTREAL, Nov. 11, 2026 /CNW/ -- AI4Eyes Medical Technologies Inc. ("AI4Eyes") today announced that it has completed U.S. Food and Drug Administration (FDA) establishment registration and device listing for its eye care platform. The company can now commercialize the platform in the United States in accordance with applicable FDA regulations.

Read the full Press Release by News Wire: 
https://www.newswire.ca/news-releases/ai4eyes-completes-fda-registration-and-listing-for-its-eye-care-platform-opening-the-path-to-u-s-commercialization-877136337.html